WebMar 31, 2024 · Stutterheim J, van der Sluis IM, de Lorenzo P, Alten J, Ancliffe P, Attarbaschi A, Brethon B, Biondi A, Campbell M, Cazzaniga G, Escherich G, Ferster A, Kotecha RS, Lausen B, Li CK, Lo Nigro L, Locatelli F, Marschalek R, Meyer C, Schrappe M, Stary J, Vora A, Zuna J, van der Velden VHJ, Szczepanski T, Valsecchi MG, Pieters R. Clinical … WebJun 17, 2024 · Children with leukemia de novo were treated according to the AIEOP-BFM-ALL-2024 protocol or the AML-BFM-2024 protocol. Patients in group III completed intensive multiagent chemotherapy, usually complicated with frequent hematological adverse events and blood transfusions; during inclusion to the study, they were on oral maintenance …
Methotrexate/tioguanine SpringerLink
WebMar 1, 2024 · Blasts collected from 21 children with T-ALL enrolled on the Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly … WebCario et al. analyzed 46 pediatric patients with Ph-like ALL treated according to AIEOP-BFM ALL (international collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia) 2000 and 2009 protocols. The stratification by risk group was the main difference between the two protocols. ... Hematology 2024, 103, 107 ... mt wellington war memorial park
Studie – ALL-BFM Studienzentrale - Uni Kiel
WebStudy 10: International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia (AIEOP-BFM ALL 2024) Acute lymphoblastic leukemia. … WebDie Studienrekrutierung wurde am 31.12.2016 beendet. Bis zur Eröffnung der Nachfolgestudie sollten neue Patienten mit einer de novo ALL in das AIEOP-BFM ALL Register gemeldet werden. Die Therapie entspricht der Standardtherapie aus dem Protokoll AIEOP-BFM ALL 2009. Sponsoring: Academic Sponsor: Universitätsklinikum Schleswig … WebApr 20, 2024 · Because current AIEOP-BFM treatment is largely ineffective for MRD-positive IKZF1 plus patients, new experimental treatment approaches will be evaluated in our upcoming trial AIEOP-BFM ALL 2024. Trial registration: ClinicalTrials.gov NCT00430118 . Publication types Research Support, Non-U.S. Gov't MeSH terms Child how to make special character on keyboard